ACSS2 and osteosarcoma: Results showed that the expression levels of SLC7A7 and ACSS2 were significantly decreased in two osteosarcoma cell groups (U20S and 143B) compared with the osteoblast cell group (hFOB), whereas MYC was up-regulated in osteosarcoma groups (Figures 5A, B).